malat1基因


Weberetal.BMCResearchNotes2013,6:518doc.guandang.net
EvaluationoflongnoncodingRNAMALAT1asacandidateblood-basedbiomarkerforthediagnosisofnon-smallcelllungcancer
DanielGilbertWeber1* ,GeorgJohnen1 ,SwaantjeCasjens1,OleksandrBryk1,BeatePesch1,Karl-HeinzJöckel2,JensKollmeier3andThomasBrüning1
Background
Lungcanceristheleadingcauseofcancerdeathworld-wide[1]withNSCLC(non-smallcelllungcancer)asthemostprominentsubgroupaccountingforapproximately80%ofalllungcancercases.Commonly,thediseaseisdetectedinlatestagesresultinginshortsurvivalrates,whereasforpatientswithearly-stagelungcancerlongersurvivalratescouldbeobserved[2].Thus,thedetectionoflungcancerinearlystageswhenclinicalsymptomshavenotyetoccurredappearstobeapromisingoppor-tunitytodecreasemortality,becauseinmorecasesacurativetherapymightbecomepossible.
*Correspondence:weber@ipa-dguv.de
Equalcontributors1
InstituteforPreventionandOccupationalMedicineoftheGermanSocialAccidentInsurance,InstituteoftheRuhr-UniversitätBochum(IPA),Bürkle-de-la-Camp-Platz1,44789Bochum,Germany
Fulllistofauthorinformationisavailableattheendofthearticle
Inprincipal,biomarkersshouldbefeasibleforthede-tectionofcancerinearlystages.Thus,amajoraimincancerresearchistheidentificationofproperbio-markers.Keycharacteristicsofdiagnosticbiomarkersamongothersare:(i)minimally-invasivetomeasurethebiomarkerineasilyaccessiblebodyfluids,(ii)highspeci-ficitytoavoidfalse-positiveresultsincancer-freeindi-viduals,(iii)sufficientsensitivitytodetectthetumors,and(iv)robustnessagainstpotentialinfluencingfactors.Inrecentyearsbiomarkerresearchfocusedonnoncod-ingRNAs(ncRNAs),inparticularmicroRNAs(miRNAs).MiRNAsaresmallRNAmoleculeswithalengthof~22nucleotides(nt),playingacentralroleintheregulationofgeneexpression[3]andactingastumorsuppressorsoroncogenesincancer[4].Severalstudiesshowthefeasibil-ityofusingmiRNAsasbiomarkersinbodyfluidsforthediagnosisoflungcancer[5-8].However,thereisalackof
©2013Weberetal.;licenseeBioMedCentralLtd.ThisisanopenaccessarticledistributedunderthetermsoftheCreative
These products are not intended for the diagnosis...A surrogate marker such as: antibodies blood ... maximize signal–noise of a potential biomarker....
Whole blood impedance aggregometry as a biomarker for the diagnosis and prognosis of severe sepsis Michael Adamzik?, Klaus G?rlinger?, Jürgen Peters, ...
Blood Galectin-3 Predict the outcomes for patients...of a marker and disease Biomarker & Diagnosis ...non cancerous liver diseases such as cirrhosis and...
as a novel candidate biomarker for predicting the response of NSCLC patients...patients diagnosed with NSCLC were in their advanced stages at diagnosis [1...
organs, and that the expression profile of these miRNAs shows great promise as a novel non-invasive biomarker for diagnosis of cancer and other diseases....
Roilides22, C. Viscoli23 and A. J. Ullmann24...known as nonculture, biomarker detection procedures....method as recommended for the diagnosis of ...
1 as a potential novel biomarker for acute ...for the diagnosis of multiple cancers [9,10] ... as a novel class of blood-based biomarkers for...
After adjustment for IL-6 level (1.0% lower ...CIT has been proposed as a biomarker of small ... preceded the diagnosis of acute GVHD (median ...
diagnosis of neonatal infections: A systematic ...However, blood culture, as the gold standard for...biomarker specific final queries and ran the ...
of MicroRNA as Sepsis Biomarker Based on miRNAs ...The need for a timely diagnosis and accurate ...statistically more likely to be candidate disease ...
热门文档